Calidi Biotherapeutics Announces Appointment of Alfonso "Chito" Zulueta, Former President of International for Eli Lilly, to Its Board of Directors

LA JOLLA, Calif.–(BUSINESS WIRE)– #ADOC–Calidi Biotherapeutics, Inc., a Nevada corporation (“Calidi”), is a clinical-stage biotechnology company that is pioneering the development of stem cell-based delivery of oncolytic viruses, announced today the appointment of Alfonso "Chito" Zulueta to its Board of Directors, effective February 7, 2022. Zulueta brings to Calidi more than 30 years of extensive strategic, operational and financial experience in the biopharmaceutical industry. “We are extremely ex
Click here to view original post